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Sonic hedgehog (Shh) expression during limb devel-
opment is crucial for specifying the identity and
number of digits. The spatial pattern of Shh expres-
sion is restricted to a region called the zone of polar-
izing activity (ZPA), and this expression is controlled
from a long distance by the cis-regulator ZRS. Here,
members of two groups of ETS transcription factors
are shown to act directly at the ZRS mediating a
differential effect on Shh, defining its spatial expres-
sion pattern. Occupancy at multiple GABPa/ETS1
sites regulates the position of the ZPA boundary,
whereas ETV4/ETV5 binding restricts expression
outside the ZPA. The ETS gene family is therefore
attributed with specifying the boundaries of the
classical ZPA. Two point mutations within the ZRS
change the profile of ETS binding and activate Shh
expression at an ectopic site in the limb bud. These
molecular changes define a pathogenetic mecha-
nism that leads to preaxial polydactyly (PPD).
INTRODUCTION
The zone of polarizing activity (ZPA) was experimentally defined
as the region located at the posterior margin of the developing
limb bud that determines digit number and identity (Hill, 2007;
Tickle, 2006). The polarizing activities attributed to the ZPA are
mediated by sonic hedgehog (SHH) which is postulated to act
as a diffusible morphogen. A number of models have been
proposed to explain Shh activity (Towers and Tickle, 2009) and
most recently, SHH was shown to act as both a morphogen
and a mitogen to coordinate digit formation by integrating
growth with digit specification during limb development (Towers
et al., 2008; Zhu et al., 2008). The restricted spatial expression
within the ZPA is an essential element of all the proposedmodels
of Shh function (Ahn and Joyner, 2004; Harfe et al., 2004; Yang
et al., 1997).
A critical step in understanding the complexity of Shh expres-
sion was the identification of the cis-regulatory element called
the ZRS for ZPA regulatory sequence (Lettice et al., 2002,Developm2003) (also called MFCS1 [Sagai et al., 2005]). The ZRS
comprises 800 bp of a multispecies conserved sequence
and encodes most, if not all, of the information that regulates
the spatiotemporal pattern of Shh expression in the developing
limb bud. The ZRS is the paradigm for long-range gene regula-
tion, operating over 1 Mb to regulate Shh (Lettice et al., 2003;
Sagai et al., 2005). Single point mutations in the human ZRS
are found in patients presenting with a range of limb skeletal
malformations. These include preaxial polydactyly type 2
(PPD2), triphalangeal thumb polysyndactyly (TPTPS), syndactyly
type IV (SD4), and Werner’s mesomelic syndrome (WMS),
collectively referred to as ZRS-associated syndromes (Lettice
et al., 2003, 2008; Farooq et al., 2010; Furniss et al., 2008; Gur-
nett et al., 2007; Semerci et al., 2009;Wieczorek et al., 2010). The
point mutations function to generate ectopic expression at the
anterior margin of the limb bud (Furniss et al., 2008; Lettice
et al., 2008), which is the underlying cause of PPD.
Here, members of the large group of ETS transcription factors
(Sharrocks, 2001) are shown to play distinct roles in the spatial
pattern of Shh. Occupancy at multiple ETS sites, which bind
the factors GABPa and ETS1, regulates the position of the Shh
expression boundary in the limb, thus defining the ZPA. Multiple
binding of ETV4 and ETV5 at the ZRS, in contrast, represses
ectopic Shh expression outside the ZPA. In addition, we show
that two PPD mutations disrupt the balance in number of ETS
binding sites derepressing expression in the anterior limb bud.
RESULTS
Multiple ETS Sites Identified in the ZRS
The notion of ‘‘homotypic clustering’’ (Gotea et al., 2010; Lifanov
et al., 2003; Wagner, 1999) suggests that cis-regulators contain
multiple sites for crucial regulatory factors. Analysis of the
ZRS identified a 7 bp motif (AGGAAG/AT) that is repeated five
times (Figure 1A), with each repetition located in a highly
conserved position (Figure S1A available online). This purine-
rich sequence is contained within the consensus for the 8 bp
ETS1 binding motif (C/G/AAGGAA
G/AT) found in putative distal
regulators of genes in T cells (Hollenhorst et al., 2009). None of
the numerous point mutations in the ZRS that cause limb defor-
mities fall within these conserved motifs; however, mutations
identified in two families with PPD2, Family A & C (AC) (Gurnett
et al., 2007) and an Australian family (AUS) (E. deGraaff, personalental Cell 22, 459–467, February 14, 2012 ª2012 Elsevier Inc. 459
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Figure 1. Point Mutations Alter Shh Expression and Protein Binding Profiles
(A) Schematic showing the ZRS (yellow box), which resides within intron 5 of LMBR1, 1 Mb for the Shh gene. The positions of the ETS sites 1–5 and ETV sites A
and B identified within the ZRS aremarked by blue and green boxes, respectively. The sequences around themutations identified in families with PPD (Family AC
and AUS) are shown.
(B and C) Limbs from transgenic animals carrying wild-type (B) andmutant (C) ZRS reporter constructs (forelimb buds are shown on top and hindlimb buds below)
demonstrate that the AUS mutation results in expansion of the posterior expression (compare to B) and ectopic staining in the anterior mesenchyme (arrows).
(D–H) EMSA analysis of nuclear extracts from anterior (A) and posterior (P) halves of E11.5 limb buds.
(D) Nuclear extract was incubated with ds-oligos containing theWT, AC, or AUS sequence. TheWT sequence produced a specific band (1); the AC point mutation
resulted in a higher migrating band (2); and the AUS mutation produced a combination of WT and AC binding; bands 1 and 2. A nonspecific (NS) band was
observed for all ds-oligos.
(E–G) EMSA using the ACds-oligo (E),WT ds-oligo (F), and AUS ds-oligo (G), and using an unlabeled NS sequence, ETS consensus sequence (EtsCon),WT, or AC
oligonucleotide as their competitors.
(H) Comparison by EMSA of the binding for thewild-type ZRS sites 1–5, showing a greater extent of binding to the ACmutant site and sites 1 and 3. The unlabelled
AC oligonucleotide (lanes labeled +) specifically competes for band 2.
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ETS Factors Regulate Shh Spatial Expressioncommunication), convert the surrounding sequence to additional
ETS motifs (Figure 1A).
Transgenic analysis using a construct containing the ZRS
drives expression of the LacZ reporter gene in the expected
posterior position in the limb (Furniss et al., 2008; Lettice et al.,
2003, 2008) (Figure 1B). Addition of the AUS point mutation to
the ZRS was sufficient to drive the ectopic expression at the
anterior margin of E11.5 limb buds (Figure 1C, arrows). (The
number of transgenic embryos is reported in Table S1.)
The mutation also caused an overall increase in the width of
posterior expression such that the boundary extended deeper
into the middle of the limb (Figure 1C).
Differential Binding at the Mutant and Wild-Type
Sites of the ZRS
The protein-binding profile associated with the 7 bp motif was
analyzed by electrophoretic mobility shift assays (EMSAs) using
biotin-labeled double-strand oligonucleotide (ds-oligos) probes
and nuclear extracts from E11.5 embryonic limbs. Initially, the
AUS and AC mutant sites were analyzed using a series
of 24 bp ds-oligos (Figure 1A) spanning either the wild-type
sequence (WtB) or the mutant sequences. The WtB sequence
probe produced a single specific band (band1 in Figure 1D),
which was replaced by a higher migrating band in the presence
of the ACmutation (band 2 in Figure 1D). In comparison, the AUS
mutant probe exhibited a combination of both the WtB and AC
mutant band-shift patterns. Specificity of binding was confirmed
using unlabelled competitors for either theWtB or the ACmutant
sequence (Figures 1E–1G). An unrelated sequence (Fisher et al.,
1992) that contained the 8 bp ETS1 CAGGAAGT motif (desig-
nated EtsCon) competed for the upper band detected by both
the AC (Figure 1E) and AUS (Figure S1B) probes; whereas, the
WtB probe competed but with an appreciably lower affinity
(Figure 1F). In contrast, competition with the unlabelled WtB
sequence did not affect the AC banding pattern (Figure 1E) but
did disrupt binding of the lower band detected with the AUS
sequence (Figure 1G). These data are consistent with the two
point mutations binding similar proteins (Figure 1A) at closely
apposed positions. The two mutations affect wild-type protein
binding differently; whereas the AC mutation causes replace-
ment of wild-type binding, the AUS mutation allows binding of
either protein.
The five endogenous AGGAAG/AT sites within the 800bp ZRS
(Figure S1A) were also analyzed. ds-Oligo probes for sites 1, 2
and 3 each generated a band that migrated to the same position
as that for the AC probe (Figure 1H) and showed specificity for
binding by competition with the unlabelled AC probe. Site 4
probe did not detectably bind a protein while site 5 bound an
unidentified, higher migrating band which was not competed
with the AC sequence.
Identification of the Factors that Bind the ZRS In Vivo
A number of ETS family members are expressed in the early-
stage limb and are distributed along the distal mesenchyme.
Ets1 and Ets2 (Ristevski et al., 2002) (Figures 2A and 2B) are
expressed in the posterior mesenchyme overlapping the Shh
domain in the limb bud at E10.5 and by E11.5 extend distally,
incorporating the anterior margin (Figure 2A). Etv4 and Etv5
(also called Pea3 and Erm, respectively) (Figure 2C and 2D)Developm(Mao et al., 2009; Zhang et al., 2009) are expressed in the
mesenchyme along the entire distal edge.Gabpa (EMAGE:2836)
(Ristevski et al., 2004) is reportedly more highly expressed in
the distal mesenchyme in the posterior margin of the limb and
Elf1 (EMAGE:1462) is expressed throughout the entire limb
mesenchyme (Richardson et al., 2010).
To investigate the binding of candidate ETS proteins to the
ZRS sequences, we used ETS antibodies specific for ETS1,
ETS2, GABPa, ELF1, ETV4, and ETV5. Western blot analysis of
limb extracts (Figure 2E) showed that these proteins are
produced in both anterior and posterior halves of the limb bud
and are enriched in the nuclear extracts. EMSA analysis showed
that the anti-ETV4 (aETV4 in Figure 2F) antibody depleted the
binding of the wild-type protein responsible for the WtB banding
pattern, whereas the anti-ETS1 antibody (aETS1 in Figure 2F)
depleted the protein binding to the upper band of the AC
sequence. The other antibodies did not detectably affect the
banding pattern (data not shown).
The sequence that ETV4 binds encompasses the noncanoni-
cal site AGAAAAT (referred to as ETV4 site B) (Figures 1A and
S2A) (Xin et al., 1992). A second ETV4 binding site found to
contain the AGAAA sequence (referred to as site A) (Figures 1A
and S1) is the site of the previously published PPD2 mutation
Belg2 (Lettice et al., 2003). The Belg2 mutation, which converts
the sequence to AGGAA, was previously shown to drive ectopic
expression in transgenic assays (Lettice et al., 2008). EMSA
demonstrated that ETV4 binds the Belg2 wild-type ds-oligo
(WtA), as confirmed by depletion with the ETV4 antibody
(aETV4 in Figure 2G). Analysis of the mutant Belg2 sequence,
however, showed binding to an additional unidentified factor
(band 2 in Figure 2G).
To establish that ETS factors bind directly to the ZRS in the
limb, we performed chromatin immunoprecipitation (ChIP) in
nuclear extracts from whole autopods of E11.5 embryonic limbs
with the series of antibodies above. GABPa and ELF1 were of
particular interest, given that recent analysis of ETS1 binding
in vivo showed co-occupation by these factors at a substantial
subset of sites (Hollenhorst et al., 2007, 2009). In our initial
screen of the ChIP, neither the ETS2 nor the ELF1 antibody
showed any appreciable binding to the ZRS using qPCR (data
not shown). Further analysis using high-density tilingmicroarrays
showed the binding of both ETS1 and GABPa to the ZRS region
(Figure 2H). The binding profiles suggested that GABPa
occupied the whole region of the ZRS, whereas ETS1 binding
overlapped but was skewed toward the 30 end of the ZRS.
Accordingly, the two sites at the 30 end (sites 4 and 5) contain
the sequence AGGAAAT (Figure S1A), while the remaining sites
contain AGGAAGT. The Shh gene (Figure 2H), including the
promoter, and other control regions showed no binding to any
of these ETS factors. ELF1 was used as a negative control and
showed no binding (Figure 2H) at the ZRS, while appreciable
binding was detected at a clustering of AGGAAA sites located
near the 50 end of an uncharacterized SH3-containing gene
(30Hba, Figure 2H).
ETV4 and ETV5 act to repress Shh expression in the posterior
margin of the limb bud to ensure that no ectopic production
occurs (Mao et al., 2009; Zhang et al., 2009). In limb extracts,
both the anti-ETV4 and the anti-ETV5 antibodies detect binding
to the ZRS region (Figure 2H). ETV4 binding appeared as twoental Cell 22, 459–467, February 14, 2012 ª2012 Elsevier Inc. 461
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Figure 2. ETS Factors Are Expressed in the Limb and Bind to the ZRS
(A–D) Whole-mount in situ hybridization analysis for Ets1 (A), Ets2 (B), Etv4 (C), and Etv5 (D) are shown in E11.5 embryos and limb buds.
(E) Western blot analysis using antibodies raised against ETS factors, designated aETV4, aETV5, aETS2, aELF1, aETS1, and aGABPa, and against histone H3
(aH3) and actin (aactin), with nuclear extracts from the anterior (A) and posterior (P) halves of the limb buds (E11.5). Also shown is a comparison between limb
nuclear extracts (NE) and cytoplasmic extracts (CE). aH3 and aactin were used as loading controls.
(F) EMSA shows WtB and AC ds-oligo binding in nuclear extracts depleted for ETV4 or ETS1 using specific antibodies (aEtv4 and aEts1). (IgG was used as
a nonspecific control.) Extracts from anterior (A) or posterior (P) halves or whole limbs (L) from E11.5 limb buds were used. Band 1 observed with the WtB probe
was specifically depleted by the addition of aETV4 antibody, while Band shift 2 observed with the AC probe was specifically depleted by the addition of aETS1
antibody.
(G) EMSAs were conducted with ds-oligos containing the sequence for the wild-type ETV4 site A (WtA) or the Belg2 mutation (Bg). WtA ds-oligo shows a specific
band (1) while that for Bg sequence gives an additional higher migrating band (2). The anti-ETV4 antibody depletes Band 1 observed with WtA and Bg probes
(nonspecific IgG used as control).
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two predicted ETV4 sites. Surprisingly, ETV5 occupies a broad
region of >5 kb with a peak of binding over the whole of the
ZRS (Figure 2H). ETV5 binding is highly specific for the ZRS
region, as shown by the tiling microarray over the whole 1 Mb
of the Shh locus (Figure S2B). ETV5 binds the ZRS directly; the
broad region may reflect the high density of AGAAAG/A sites
available at nearby sites (Figure 2H).
Ets1 is expressed not only in the posterior mesenchyme but
also along the anterior margin overlapping the ectopic domain
driven by the AUS mutation (Figure 1C). To determine whether
ETS1 binds to the ZRS at both the anterior and the posterior
halves, we dissected limb buds at E11.5 for ChIP. qPCR showed
significant binding of ETS1 at the ZRS (Figure S2C) in both the
anterior and posterior halves, suggesting that the ZRS is open
for factor interactions on the quiescent as well as the active
side of the limb.
Ectopic Shh Expression Occurs by Two Mechanisms
We investigated two possible explanations for the ectopic
expression driven by the AUS point mutation. First, by displacing
the ETV4/ETV5 repressor at site B (Figure 1A), the binding of
GABPa/ETS1 to the mutant site may lead to ectopic activation.
To investigate this possibility, we generated two different
mutations that disrupt site B. Neither a terminal deletion of
44 bp (tDel, Figure 3A), which removes the entire site, nor
replacement of three base pairs within the ETV4 binding site
(AGAAAAT/AGAGCGT) (-ETVB, Figure 3B) caused ectopic
expression in transgenic embryos. In fact, expression levels
decreased but importantly, the spatial boundary appears unaf-
fected. Thus we tested a second possibility, specifically that
the AUS mutation, by creating an additional AGGAAGT site,
may directly drive ectopic activity. An extra AGGAAGT site was
added to the ZRS. A putative neutral position, a variable stretch
of Ts that differ in mammalian species (human has six Ts, mouse
has eight, and rat has 22), was selected as the site for the inser-
tion (Figure 3E). Themodified ZRS generated ectopic expression
activity (Figure 3G), whereas the control (insertion of seven Ts
[Figure 3E]) showed no detectable ectopic expression (Fig-
ure 3F). These data show that an additional GABPa/ETS1 site
is sufficient, on its own, to generate ectopic expression.
These analyses, as a consequence, raised questions about
the direct role ETV4/ETV5 plays in restricting ectopic expression
of Shh. To investigate the regulatory role of the ETV4/ETV5
proteins further, the three-base-pair replacement in site B, dis-
cussed above, was made in site A. Similar to the case with
loss of only site B, no ectopic expression was observed with
loss of site A (Figure 3C). The double mutation of both sites A
and B, however, resulted in ectopic expression along the distal,
anterior margin of the limb (Figure 3D). The simultaneous
removal created a loss of ETV function and confirms that this
ETV subfamily acts directly at the ZRS to restrict the expression
pattern of Shh to the posterior margin.(H) ChIP using antibodies to five different ETS factors (ETV4, ETV5, Elf1, ETS1, an
using three different genomic regions, the y axis is Log2 for each ChIP/input DNA a
containing the ZRS is highlighted by the gray shading. As controls, the whole of
a-globin locus (30Hba) are shown. Scale bars are shown at the top and the positio
sites at the bottom of each panel.
DevelopmThe Endogenous GABPa/ETS1 Sites Define the
Boundary of Shh Expression
To investigate the consequences of having multiple, clustered
ETS sites, the five endogenous sites in the ZRS were systemat-
ically inactivated (AGGAAG/AT/ CTTAA
G/AT) and evaluated by
the transgenic assay (Figures 3H–3Q). For each transgenic, the
relative domain widths of the limb buds were measured as
indicated in Figure 3H and plotted. The mean domain widths of
fore- and hindlimbs combined for each experimental group
were then compared. The mean size of the expression domain
was found to be highly significantly related to the combination
of ETS sites that were disrupted (analysis of variance [ANOVA]
p < 0.0001). The results of subsequent pairwise comparisons
(Tukey’s HSD test) are shown in Table S2.
Disruption of both sites 1 and 3 (the two sites that showed
highest affinity for ETS1 binding in vitro) (Figure 3L) resulted in
a significant reduction (p values in Table S2) in reporter-gene
expression as compared to the wild-type construct (Figure 3I),
whereas singly (Figure 3J), neither site detectably changed
limb-bud expression (Figures 3I–3K). Disruption of additional
sites resulted in no further reduction in the expression domain
(Figure 3H). The activity levels of sites 1 and 3 were further
analyzed. The sole presence of either one of these sites (Figures
3O and 3P) established boundaries of expression approaching
that of the wild-type construct, whereas the presence of both
1 and 3 together (Figure 3Q) generated a wide expression
domain that was indistinguishable. Sites 2, 4, and 5 (Figure 3L)
showed some activity, as in the presence of either site 1 or 3,
producing an expression domain similar to that of the wild-
type (Figure 3H).
The addition of the extra AUS mutant site caused a further
upregulation in transgenic embryos, with expression extending
deeper into the center of the limb (Figure 3H). The construct
carrying the AUSmutation but lacking site 1 showed little change
(Figure 3R), whereas, again, removing sites 1 and 3 caused
a retraction of the expression boundary (Figure 3S) but only to
the extent of that generated by the wild-type construct (Fig-
ure 3H). Further removal, deleting sites 1, 2 and 3 together (Fig-
ure 3T), or all five sites, caused little further change in expression,
suggesting that this single high-affinity site is sufficient for gener-
ating the wild-type transgenic expression. With the inclusion of
the AUS mutation, ectopic anterior expression occurs in the
limbs (Figure 1C); however, in the absence of both sites 1 and
3 the number of limbs with ectopic expression decreases from
83% to 33%, and in the absence of all five sites (Table S1), no
ectopic expression was detected, suggesting that the wild-
type ETS sites assist in the ectopic expression. In addition, an
earlier stage of limb development was examined (E10.5) using
constructs containing the wild-type ZRS, and with site 1 and
sites 1 and 3 disrupted and with the AUS mutation added. The
relative size differences of the expression domains were
unchanged; thus, no temporal differences were apparent (data
not shown).d GABPa) analyzed by hybridizing to tiling microarrays. Summary is presented
nd the x axis represents a segment of DNA from themicroarray. The DNA region
the Shh coding region plus promoter (Shh) and the region downstream of the
ns of potential ETS1/GABPa (AGGAAG/A) and ETV4/ETV5 (AGAAA
G/A) binding
ental Cell 22, 459–467, February 14, 2012 ª2012 Elsevier Inc. 463
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Figure 3. Transgenic Analysis of Embryos Carrying Mutant ZRS Sequences
(A–D) Limbs from transgenic embryos carrying the following mutant ZRS sequences: the 44 bp terminal deletion (tDel) (A), the 3 bp change in the ETV4 Site B
(-ETVB) (B), and Site A (-ETVA) (C). Disruption of both sites in combination (D) results in ectopic expression in the anterior of the limb.
(E–G) Position of the run of Tswithin the ZRS and the changes added are shown in red. Expression due to these changes is shown by comparison of the addition of
seven Ts (F) and the extra ETS1/GABPa site (AGGAAGT) (G). Ectopic expression is detected in (G).
(H) Graphical representation of the expression pattern resulting frommutations within the endogenous ETS sites. Expression pattern is the ratio of the width of the
expression domain divided by the width of the limb, expressed as a percentage (see p values in Table S2).
(I–Q) Examples of transgenic embryos for the ETS mutations analyzed are shown. The ETS sites remaining are depicted in the lower-left-hand corner of each
figure.
(R–T) Transgenic embryos that represent the addition of the AUS mutation in combination with ETS site mutations are shown. A close-up of a forelimb for each is
shown in the insets.
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Asymmetric expression is essential for SHH morphogen activity
in the developing limb. The ETS gene family plays a central role in
the Shh spatial pattern, both positioning the expression of Shh at
the posterior margin of the limb and repressing ectopic expres-
sion at the anterior margin. The limitation of the cell-free
approach to identify the full spectrum of ETS family members
was highlighted by the in vivo ChIP analysis, which identified
additional binding factors. The co-occupancy identified for
ETS1 and GABPa at the ZRS corresponds to the genome-wide
occupancy analysis of Hollenhorst et al. (2009), which shows464 Developmental Cell 22, 459–467, February 14, 2012 ª2012 Elsevthat the vast majority of GABPa sites colocalize with those that
bind ETS1 sites. In addition, the ChIP approach showed that
both ETV4 and ETV5 act directly at the ZRS. Even with the
resolution afforded by ChIP in combination with tiling microar-
rays, it is difficult to determine whether GABPa and ETS1 or
ETV4 and ETV5 are competing for the same sites; however,
the differences in profiles do suggest that there are site
preferences.
Redundancy within this large group of ETS factors compli-
cates both the biochemical and genetic analysis of gene func-
tion of individual family members. However, sequential inactiva-
tion of the ETS sites provided an approach to investigate theier Inc.
AB
Figure 4. A Model Representing the Fine Balance
of ETS Factor Binding and Their Effects on Shh
Expression
(A) Representation of the expression patterns of the acti-
vating ETS factors (ETS1 and GABPa) and the repressing
ETS factors (ETV4 and ETV5).
(B) A summary diagram of how four of the transgenic
constructs are proposed to interact with the available ETS
factors in the limb, with the expression pattern observed
for each construct shown in the middle. The change in the
balance between activating and repressing activity rep-
resented on the right shows the relative balance in the
anterior and posterior margins of the limb. The size of the
lettering represents the relative amounts of the activating
and repressing activities.
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ETS Factors Regulate Shh Spatial Expressionrole these factors play. ETS1/GABPa directs the position of
the Shh expression boundary delineating the experimentally
defined ZPA. Our data suggest that Shh expression is most
substantially affected by either site 1 or 3, and it appears that
the two sites act cumulatively to achieve the wild-type position
of the spatial boundary. Clearly, other sites participate given
that, for example, the boundary produced by site 1 is
augmented by the presence of sites 2, 4, and 5. The five
binding sites do not participate equivalently, and affinity of
binding, as detected in the EMSA, is probably part of the expla-
nation. The combinatorial nature of these sites is further sup-
ported by the addition of the AUS mutant site in the ZRS, which
causes extension of the expression boundary further into the
middle of the limb bud. This mutant binding site is the most
active of the sites analyzed and, on its own, is capable of
driving expression to the approximate boundary of that gener-
ated by the wild-type construct. ETS1 and GABPa are ex-
pressed at highest levels in the posterior domain of the limb.
We suggest that the levels of ETS1/GABPa and the multiple
binding sites act in concert to establish a regulatory balance
at the ZRS to, first, adjust the position of the Shh boundary
and, second, in combination with the repressive activity ofDevelopmental Cell 22, 459ETV4/ETV5, to restrict expression to the ZRS
(see summary in Figure 4).
Two ETV4/ETV5 binding sites were identified
in the ZRS. In transgenics, a single ETV binding
site is sufficient to repress ectopic expression;
the loss of both sites results in the loss of
repressor activity and as a consequence activa-
tion of ectopic expression. Previously, expres-
sion of both ETV4 and ETV5 in the distal mesen-
chyme of the limb bud was shown to be
maintained by FGF signaling emanating from
the AER (Mao et al., 2009; Zhang et al., 2009).
FGF is known to be essential for limb outgrowth
and maintenance of Shh expression. We show
that ETV4/ETV5 binding links FGF signaling
directly to regulation at the ZRS, showing an
unexpected role for FGF, acting through these
factors, to repress expression at the anterior
margin of the limb.
The AUS mutation has an additional pathoge-
netic activity, which is to drive ectopic expres-sion in the developing limb bud. We show that the wild-type sites
contribute to the ectopic expression but are dependent on the
additional activity provided by the extra binding site. Previous
data suggest that the ZRS is primed for activity in both the ante-
rior and posterior margins of the limb bud (Amano et al., 2009). In
accord, we show that the ZRS is open and fully capable of
binding to activating factors such as ETS1 in the anterior domain
of the limb bud. As a result, a new, mutant site such as that
produced by the AUS mutation would be capable of binding
ETS factors at both the normal and the ectopic domains of
expression. ETV4/ETV5 is crucial for ensuring that at the primed
ZRS, ectopic anterior expression does not occur during limb
development (Figure 4). The addition of an extra single high-
affinity ETS binding site (as with the AUS mutation) apparently
overrides ETV4/ETV5 repression, causing the loss of Shh spatial
restriction. These molecular events lead to the ectopic expres-
sion of Shh that underlies the preaxial polydactyly caused by
the AC and AUS mutations.
The high conservation throughout the 770 bp of the ZRS
suggests that there is scope for binding a complex mixture of
factors. The ETS factor binding sites are most likely functioning
alongwith the binding of other factors at the ZRS. In combination,–467, February 14, 2012 ª2012 Elsevier Inc. 465
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ETS Factors Regulate Shh Spatial Expressionthese proteins would endow the ZRS with the properties that
would not only delineate the boundary but also dictate precise
temporal activity. In addition, multiple ETS sites along with other
factorsmay encode an activity that is sufficiently robust to enable
long-range recognition and activation of the Shh promoter.
EXPERIMENTAL PROCEDURES
Materials
The antibodies used were: IgG (Santa Cruz, sc-2025), ETS1 (Maier et al.,
2003), ETS2 (a kind gift from R. M. Roberts), ETV4 (Abcam, ab860902),
ETV5 (Abcam, ab102010), GABPa (Santa Cruz, sc-22810), and ELF1 (Santa
Cruz, sc-631).
Transgenic Assay and In Situ Hybridization
Transgenic embryos were made and stained in accordance with standard
techniques (Lettice et al., 2003), and assembly of mutant ZRS constructs is
described in the Supplemental Information.Whole-mount in situ hybridizations
were described previously (Hecksher-Sørensen et al., 1998). The Etv4, Etv5,
and Ets2 probes were transcribed from EST cDNA clones (Geneservice),
whereas the Ets1 probe was generated by RT-PCR and cloned into pZero
(Invitrogen). Primers used to amplify Ets1 were 50-GGAGCATCTAGAGAT
CCTGC-30 and 50-CAGCCATCTCCTGTCCAGC-30.
Measuring the Depth of ZRS Staining and Statistical Analysis
Measurement of the extent of expression in each transgenic in the ZRS shown
in Figure 3H was measured in Photoshop and calculated as a percentage of
the width of the limb bud (to correct for stage differences between the
embryos), as shown in Figure 3H.
Statistical comparisons were performed using the statistical package
R (http://www.r-project.org/) (R Development Core Team, 2008). For these
comparisons, the hind- and forelimb data for each injected construct
were combined and a one-way analysis of variance (ANOVA) was used to
compare the mean values between each of the 19 groups. The result was
highly statistically significant. Therefore, further pairwise post-hoc tests were
performed to compare the individual groups using Tukey’s HSD (honestly
significant difference) test. The table of significance values is found in
Table S2.
Electrophoretic Mobility Shift Assays
Nuclear extracts were prepared directly from embryonic limb tissue (E11.5).
EMSA analysis is described in detail in the Supplemental Information.
Chromatin Immunoprecipitation and Tiling Microarrays
Cells from dissected E11.5 limbs were fixed with 1% formaldehyde (25C,
10 min) and stopped with 0.125 M glycine. Crosslinked ChIP was performed
as described (Stock et al., 2007). In brief, the nuclei were sonicated using a
Diagenode Bioruptor (Leige, full power 30 s on, 30 s off, in an ice bath for
50 min) to produce fragments of <300 bp. Chromatin (350 mg) was incubated
with 5 mg prebound (to Protein A or G magnetic beads, Invitrogen) IgG
(Santa Cruz, sc-2025) or antibodies raised to ETS1 (Maier et al., 2003), ETV4
(Abcam, ab860902), ETV5 (Abcam, ab102010), GABPa (Santa Cruz, sc-
22810), or ELF1 (Santa Cruz, sc-631) in the presence of 50 mg of BSA, washed,
and eluted. Reverse crosslinked DNA was purified with Proteinase K
(Glenaxxon) and QIAGEN PCR purification kit. ChIP DNA and input DNA
were amplified (WGA2 kit, Sigma), labeled, and hybridized according to the
manufacturer’s protocol to a 33 720,000 probe custommicroarray containing
specific tiled regions encompassing 8.2 megabases of the mouse genome
(Nimblegen). The array platform number is GPL14936 and the GEO accession
number for the ChIP data is GSE33997.
Microarray data were analyzed in R/Bioconductor (http://genomebiology.
com/2004/5/10/R80) with the Epigenome (PROT43) protocol (http://www.
epigenome-noe.net/WWW/researchtools/protocol.php?protid = 43) with the
following parameters. The mean signal intensity of the four replicate probes
on each array was taken. Loess normalization was used within arrays to
correct for the dye bias, and scale normalization was used within the repli-
cates group to control interarray variability. The log enrichment for each466 Developmental Cell 22, 459–467, February 14, 2012 ª2012 Elsevgroup was calculated by subtracting the mean of log2 input intensities
from the mean of log2 enriched intensities. Probes were tested for significant
enrichment using the significance analysis of microarrays (SAM) technique
(Tusher et al., 2001), and the local false discovery rate based on the SAM
statistic was calculated using the Locfdr R package (Efron, 2007). A false
discovery rate of 0.05 was used as the significance cutoff. The median value
of each probe was then calculated from a five-probe rolling window to
overcome outliers with values that are very different from their neighboring
probes.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.devcel.2011.12.010.
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